Active Not Recruiting OBSERVATIONAL NCT06782945
Investigating the Effectiveness of 2 Different Doses of BIOHM FX Probiotic Blend in Improving Digestive Symptoms
A Direct-to-Consumer Placebo-controlled Study Investigating the Effectiveness of 2 Different Doses of BIOHM FX Probiotic Blend in Improving Digestive Symptoms in Individuals With Moderate Gastrointestinal Discomfort
Sponsor: Biohm Technologies
Conditions
Moderate Gastrointestinal Discomfort
Interventions
BIOHM FX Probiotic Blend
Updated 1 time since 2025 Last updated: Jan 14, 2025 Started: Jul 24, 2024 Primary completion: Jan 8, 2025 Completion: Mar 4, 2025
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
Listed as NCT06782945, this observational or N/A phase trial focuses on Moderate Gastrointestinal Discomfort and remains ongoing. Sponsored by Biohm Technologies, it has been updated 1 time since 2024, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
1 version recorded Active Not Recruiting
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Biohm Technologies
- People Science, Inc.
Data source: Biohm Technologies
For direct contact, visit the study record on ClinicalTrials.gov .